Gonadotropins in the Management of Couple Infertility: Toward the Rational Use of an Empirical Therapy

• Published in: Seminars in reproductive medicine Vol. 41; no. 6; p. 258
• Main Authors: Romeo, Marilina, Donno, Valeria, Spaggiari, Giorgia, Granata, Antonio R M, Simoni, Manuela, La Marca, Antonio, Santi, Daniele
• Format: Journal Article
• Language: English
• Published: United States 01.11.2023
• ISSN: 1526-4564
• DOI: 10.1055/s-0043-1777837

Although epidemiology shows that both men and woman can experience infertility, the female partner usually experiences most of the diagnostic and therapeutic burden. Thus, management of couple infertility is a unique example of gender inequality. The use of exogenous gonadotropins in assisted reproductive technology (ART) to induce multifollicular growth is well consolidated in women, but the same is not done with the same level of confidence and purpose in infertile men. Indeed, the treatment of idiopathic male infertility is based on an empirical approach that involves administration of the follicle-stimulating hormone (FSH) in dosages within the replacement therapy range. This treatment has so far been attempted when the endogenous FSH serum levels are within the reference ranges. According to the most recent evidence, a "substitutive" FSH administration may not be effective enough, while a stimulatory approach could boost spermatogenesis over its basal levels without adverse extragonadal effects. This article aims to describe the rationale behind the empirical application of gonadotropins in couple infertility, highlighting the need for a change in the therapeutic approach, especially for the male partner.